Inventor
DAVID W. MILES
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes50%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
B01DSeparation6%
C08BPolysaccharides6%
C08LCompositions of macromolecular compounds6%
PatentTitleYear
12,433,931Lisinopril formulations202512,186,360Lisinopril formulations202512,128,083Lisinopril formulations202411,795,241Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same202311,771,733Lisinopril formulations202311,179,434Lisinopril formulations202111,173,141Enalapril formulations202111,141,405Enalapril formulations2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to AZURITY PHARMACEUTICALS INC (5)· patent assignee history
2021–2023Patents assigned to SILVERGATE PHARMACEUTICALS INC (2)· patent assignee history
2021–2025Based in US· patent location history
2023Patents assigned to CYDEX PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AZURITY PHARMACEUTICALS INC | 5 | 2021–2025 |
| SILVERGATE PHARMACEUTICALS INC | 2 | 2021–2023 |
| CYDEX PHARMACEUTICALS INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |